Economics

December 2, 2016 Delinkage Meeting: Powerpoints and Video Recording

On December 2, 2016, KEI hosted a workshop on delinkage at the United States Senate.

A recording of the event is available on YouTube: https://www.youtube.com/watch?v=BaoOHtH_d7U

Slide presentations are available here:

Research and Development Cost Transparency Legislation

This page features KEI blog posts, testimony, comments, and research on the transparency of the costs of research and development in the pharmaceutical sector.

United States Transparency Legislation

16 March 2017: KEI testifies before a Maryland House of Delegates Subcommittee on transparency legislation

10 March 2017: 2017 R&D Cost Transparency Proposals in the United States

drugsalesdata

There is a form for entering data on drug sales, here.

Social Goods

2013. Manon Anne Ress. Global Public Goods, transnational public goods: some definitions : How are global public goods defined? Definitions of 'global public goods' as outlined by major contributors to the international debate. (html)

Manon's 2013 collection of quotes is very relevant, but here are some additional definitions. The discussions by Musgrave and Steiner are probably closer to how people actually define public or social goods in practice.

Global Public Goods, transnational public goods: some definitions

How are global public goods defined? Definitions of 'global public goods' as outlined by major contributors to the international debate.

Manon Anne Ress,

August 23, 2013

World Health Organization WHO Definition

Donations

Enhanced Charitable Deductions for Businesses, Counting on Charity, An accounting professor's view of the nonprofit world. WEDNESDAY, JANUARY 30, 2013

Anil Arya and Brian Mittendorf, The Economic Consequences of Enhanced Charitable Tax Deductions, March 1, 2013. http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2208095

The Blur Banff proposal

Notes on the Blur Banff proposal*
KEI Research Note 2013:1
February 1, 2013

This is a brief note on the Blur/Banff proposal for a system of decentralized decision making and competitive intermediaries to provide money to support recorded music that is freely available. Also discussed are extensions of the competitive intermediary approach to other areas where information goods can be supplied as public goods.

2011: Survey of drug prices for 14 drugs with US government rights in patents listed in the FDA Orange Book

KEI Research Note 2011:2

Survey of drug prices for 14 drugs with US government rights in patents listed in the FDA Orange Book

Tedmund Wan
Knowledge Ecology International
November 11, 2011

Introduction

PhRMA annual industry profiles

The data tables from the annual Pharma industry profile surveys are attached below.

A few notes from the tables.

In 2002, the number of data tables in was 19. In 2003, the number of tables was reduced to 9. In 2012, the number of tables was 10.

Syndicate content